T 0747/18 (Hyaluronic acid composition / Q-MED AB) of 27.01.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T074718.20220127
- Date of decision
- 27 January 2022
- Case number
- T 0747/18
- Petition for review of
- -
- Application number
- 12702536.9
- IPC class
- A61K 45/06A61K 8/73A61K 31/728A61K 31/245A61K 9/00A61L 27/20A61K 47/22A61K 47/36A61L 31/04A61K 8/67A61Q 19/08A61K 31/445A61K 31/375A61L 27/54A61L 31/16A61K 31/167A61Q 7/00A61K 8/42
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Hyaluronic acid composition comprising an ascorbic acid derivative
- Applicant name
- Q-Med AB
- Opponent name
- ALLERGAN, INC.
Laboratoires Vivacy - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 87 (2007)European Patent Convention Art 88 (2007)European Patent Convention Art 89 (2007)
- Keywords
- Priority - main request and auxiliary requests 1-4 (partial priority), auxiliary request 6 (yes)
Amendments allowable
Amendments - auxiliary request 6 (yes)
Sufficiency of disclosure - auxiliary request 6 (yes)
Novelty - main request (yes), auxiliary request 6 (yes)
Inventive step - main request (no), auxiliary requests 1-4 (no), auxiliary request 6 (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside
The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of auxiliary request 6 filed by the appellant - patent proprietor with the reply to the statement of grounds of appeal and a description to be adapted thereto.